BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Alloprevotella |
📓
Lactobacillus rhamnosus LRa05 Alleviates Constipation via Triaxial Modulation of Gut Motility, Microbiota Dynamics, and SCFA Metabolism. Foods (Basel, Switzerland) (Foods ) Vol: 14 Issue 13 Pages: Pub: 2025 Jun 28 Epub: 2025 Jun 28 Authors Zhang J , Li Q , Liu S , Wang N , Song Y , Wu T , Zhang M , Html Article Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Alloprevotella |
📓
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease. Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 15460 Pub: 2024 Jul 4 Epub: 2024 Jul 4 Authors Aktas B , Aslim B , Ozdemir DA , Html Article Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Alloprevotella |
📓
Lactobacillus rhamnosus LRa05 Ameliorate Hyperglycemia through a Regulating Glucagon-Mediated Signaling Pathway and Gut Microbiota in Type 2 Diabetic Mice. Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 69 Issue 31 Pages: 8797-8806 Pub: 2021 Aug 11 Epub: 2021 Aug 2 Authors Wu T , Zhang Y , Li W , Zhao Y , Long H , Muhindo EM , Liu R , Sui W , Li Q , Zhang M , Publication |
| Lacticaseibacillus rhamnosus {l. rhamnosus} - Alloprevotella |
📓
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017 Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
